Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Finished Goods (2017 - 2025)

Nephros has reported Finished Goods over the past 9 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Finished Goods at $3.0 million for Q4 2025, up 31.49% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (up 31.49% YoY), and the annual figure for FY2025 was $3.0 million, up 31.49%.
  • Finished Goods for Q4 2025 was $3.0 million at Nephros, up from $2.5 million in the prior quarter.
  • Over the last five years, Finished Goods for NEPH hit a ceiling of $4.2 million in Q2 2021 and a floor of $1.6 million in Q1 2025.
  • Median Finished Goods over the past 5 years was $2.6 million (2022), compared with a mean of $2.7 million.
  • Biggest five-year swings in Finished Goods: crashed 54.0% in 2023 and later surged 44.15% in 2024.
  • Nephros' Finished Goods stood at $3.7 million in 2021, then decreased by 25.88% to $2.7 million in 2022, then fell by 20.86% to $2.1 million in 2023, then rose by 5.46% to $2.3 million in 2024, then surged by 31.49% to $3.0 million in 2025.
  • The last three reported values for Finished Goods were $3.0 million (Q4 2025), $2.5 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.